BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3877709)

  • 1. Interleukin 2 liberation and absorption capacities of rat T lymphocytes in conditions of severe adenylic nucleotide pool depletion due to adenosine deaminase deficiency.
    Thuillier L; Arenzana-Seisdedos F; PĂ©rignon JL; Munier A; Hamet M; Cartier PH
    Immunopharmacology; 1985 Oct; 10(2):89-97. PubMed ID: 3877709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consequences of adenosine deaminase deficiency on thymocyte metabolism.
    Thuillier L; Garreau F; Cartier PH
    Eur J Immunol; 1981 Oct; 11(10):788-94. PubMed ID: 6975717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of an induced adenosine deaminase deficiency on T-cell differentiation in the rat.
    Barton RW
    Cell Immunol; 1985 Oct; 95(2):297-310. PubMed ID: 3876160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.
    Bagnara AS; Hershfield MS
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2673-7. PubMed ID: 6283540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inability of immunocompetent thymocytes to produce T-cell growth factor under adenosine deaminase deficiency conditions.
    Thuillier L; Garreau F; Cartier P
    Cell Immunol; 1981 Sep; 63(1):81-90. PubMed ID: 6974051
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
    Webster AD; Ip H; Pereira S
    Clin Exp Immunol; 1982 Dec; 50(3):587-95. PubMed ID: 6299634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal model for immune dysfunction associated with adenosine deaminase deficiency.
    Tedde A; Balis ME; Ikehara S; Pahwa R; Good RA; Trotta PP
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4899-903. PubMed ID: 6968908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human B lymphocytes and thymocytes but not peripheral blood mononuclear cells accumulate high dATP levels in conditions simulating ADA deficiency.
    Goday A; Simmonds HA; Morris GS; Fairbanks LD
    Biochem Pharmacol; 1985 Oct; 34(19):3561-9. PubMed ID: 3876835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor.
    Ratech H; Thorbecke GJ; Hirschhorn R
    Clin Immunol Immunopathol; 1981 Oct; 21(1):119-27. PubMed ID: 6268339
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies of the relationship between adenosine deaminase and immune function.
    Burridge PW; Paetkau V; Henderson JF
    J Immunol; 1977 Aug; 119(2):675-8. PubMed ID: 301901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. dATP accumulation and ATP depletion in platelets in adenosine deaminase deficiency: significance for the immune response?
    Simmonds HA; Goday A; Morris GS; Fairbanks LD; Levinsky RJ
    Biosci Rep; 1984 Oct; 4(10):809-18. PubMed ID: 6335053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
    Bontemps F; Van den Berghe G
    Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2'-deoxycoformycin toxicity in murine spleen lymphocytes.
    Earle MF; Glazer RI
    Mol Pharmacol; 1983 Jan; 23(1):165-70. PubMed ID: 6602939
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro effects of adenosine deaminase inhibitors on lymphocyte mitogen responsiveness in the mouse.
    Ballow M; Pantschenko AG
    Cell Immunol; 1981 Oct; 64(1):29-43. PubMed ID: 6975175
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of ADA deficiency on cultured murine thymus transplantation.
    Hong R; Horowitz SD; Fortman C; Martin DW
    Clin Immunol Immunopathol; 1982 May; 23(2):448-58. PubMed ID: 6980759
    [No Abstract]   [Full Text] [Related]  

  • 16. Deoxyadenosine triphosphate accumulation in erythrocytes of deoxycoformycin-treated mice.
    Smith CM; Henderson JF
    Biochem Pharmacol; 1982 Apr; 31(8):1545-51. PubMed ID: 6980005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of deoxycoformycin in mice. III. A murine model reproducing multi-system pathology of human adenosine deaminase deficiency.
    Ratech H; Hirschhorn R; Thorbecke GJ
    Am J Pathol; 1985 Apr; 119(1):65-72. PubMed ID: 3872599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
    Lee N; Russell N; Ganeshaguru K; Jackson BF; Piga A; Prentice HG; Foa R; Hoffbrand AV
    Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biochemical pharmacology of (2'-R)-chloropentostatin, a novel inhibitor of adenosine deaminase.
    Jackson RC; Leopold WR; Ross DA
    Adv Enzyme Regul; 1986; 25():125-39. PubMed ID: 2433905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism.
    Simmonds HA; Panayi GS; Corrigall V
    Lancet; 1978 Jan; 1(8055):60-3. PubMed ID: 74565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.